| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 6,436 | 6,056 | 5,420 | 5,367 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 6,436 | 6,056 | 5,420 | 5,367 | | | Operating Expenses | | Research Development | 11,347 | 12,678 | 11,334 | 10,409 | | Selling General and Administrative | 3,134 | 3,203 | 3,660 | 3,499 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (8,045) | (9,825) | (9,574) | (8,541) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 526 | 1,723 | (168) | (834) | | Earnings Before Interest And Taxes | (7,519) | (8,102) | (9,742) | (9,375) | | Interest Expense | 169 | 170 | 166 | 254 | | Income Before Tax | (7,688) | (8,272) | (9,908) | (9,629) | | Income Tax Expense | 400 |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (8,088) | (8,272) | (9,908) | (9,629) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (8,088) | (8,272) | (9,908) | (9,629) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($8,088) | ($8,272) | ($9,908) | ($9,629) |
|
0.26% Nasdaq 0.00%
Income Statement
